{
    "mtblsStudy": {
        "studyStatus": "Public",
        "curationRequest": "NO_CURATION",
        "modifiedTime": "2025-01-06T14:12:05.560668",
        "statusUpdateTime": "2025-01-06T14:12:05.560668",
        "read_access": true,
        "write_access": false,
        "is_curator": false
    },
    "isaInvestigation": {
        "comments": [
            {
                "name": "Created With Configuration",
                "value": "MetaboLightsConfig20150707"
            },
            {
                "name": "Last Opened With Configuration",
                "value": "MetaboLightsConfig20150707"
            }
        ],
        "identifier": "MTBLS11126",
        "title": "Investigation",
        "description": "Created using the MetaboLights Online Editor (MOE)",
        "submissionDate": "2024-09-19",
        "publicReleaseDate": "2025-01-06",
        "filename": "",
        "people": [],
        "publications": [],
        "ontologySourceReferences": [
            {
                "comments": [],
                "name": "OBI",
                "file": "http://data.bioontology.org/ontologies/OBI",
                "version": "29",
                "description": "Ontology for Biomedical Investigations"
            },
            {
                "comments": [],
                "name": "EFO",
                "file": "http://data.bioontology.org/ontologies/EFO",
                "version": "132",
                "description": "Experimental Factor Ontology"
            },
            {
                "comments": [],
                "name": "NCIT",
                "file": "http://www.ebi.ac.uk/metabolights/ontology",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "CHEBI",
                "file": "https://www.ebi.ac.uk/ols4/api",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "NCBITaxon",
                "file": "https://www.ebi.ac.uk/ols4/api",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "MTBLS",
                "file": "https://www.ebi.ac.uk/metabolights/ontology",
                "version": "1.0",
                "description": "Metabolights Ontology"
            }
        ],
        "studies": [
            {
                "comments": [],
                "identifier": "MTBLS11126",
                "filename": "s_MTBLS11126.txt",
                "title": "Melatonin enhances function of porcine immature Sertoli cells via modulating gene expression and metabolism",
                "description": "<p>Melatonin (MT), a neurohormone synthesized and secreted primarily by the pineal gland, is of vital function to animal reproduction. However, the effect of MT treatment on porcine immature Sertoli cells (iSCs) remains unclear. Here, MT treatment (10 nM, 36 h) could elevate mitochondrial function and reduce oxidative stress, therefore inhibit apoptosis of porcine iSCs. Transcriptome profiling identified 39 differentially expressed genes (DEGs) (33 known and 6 novel) (MT vs Control), mainly involved in GO terms of steroid metabolic process, glutamine metabolic process, oxidoreductase activity and G protein coupled receptor binding, and KEGG pathways of steroid biogenesis, pyruvate metabolism, NF-kappa B and AMPK signal pathways. RT-qPCR validated 6 DEGs (Phgdh, Scd, Hmgcs1, Cytb, Pck2 and Sqle) induced by MT to be with the similar change trend to RNA-seq results. The protein level of HMGCS1 and the estradiol level were confirmed to be significantly decreased by MT (10 nM, 36 h) treatment of porcine iSCs. Inhibition of HMGCS1 in porcine iSCs could significantly reduce the level of estradiol. The levels of cholesterol content within cells and lactate in culture medium were unchanged by MT (10 nM, 36 h). 14 metabolites were significantly altered by MT (10 nM, 36 h) treatment of porcine iSCs. Which were involved in multiple vital metabolic pathways. Collectively, MT treatment of porcine iSCs could promote functions of porcine iSCs via modulating gene expression and metabolism.</p>",
                "submissionDate": "2024-09-19",
                "publicReleaseDate": "2025-01-06",
                "people": [
                    {
                        "comments": [],
                        "firstName": "Yang",
                        "lastName": "Xia",
                        "email": "caixiayang@yangtzeu.edu.cn",
                        "affiliation": "",
                        "address": "Yangtze University",
                        "fax": "",
                        "midInitials": "Cai",
                        "phone": "",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Co-Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "http://www.ebi.ac.uk/metabolights/ontology",
                                    "version": "",
                                    "description": ""
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C51812"
                            }
                        ]
                    }
                ],
                "studyDesignDescriptors": [
                    {
                        "comments": [],
                        "annotationValue": "melatonin",
                        "termSource": {
                            "comments": [],
                            "name": "CHEBI",
                            "file": "https://www.ebi.ac.uk/ols4/api",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHEBI_16796"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Sus scrofa domesticus",
                        "termSource": {
                            "comments": [],
                            "name": "NCBITaxon",
                            "file": "https://www.ebi.ac.uk/ols4/api",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/NCBITaxon_9825"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Sertoli Cell",
                        "termSource": {
                            "comments": [],
                            "name": "NCIT",
                            "file": "http://www.ebi.ac.uk/metabolights/ontology",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/NCIT_C12595"
                    },
                    {
                        "comments": [],
                        "annotationValue": "untargeted metabolites",
                        "termSource": {
                            "comments": [],
                            "name": "MTBLS",
                            "file": "https://www.ebi.ac.uk/metabolights/ontology",
                            "version": "1.0",
                            "description": "Metabolights Ontology"
                        },
                        "termAccession": "http://www.ebi.ac.uk/metabolights/ontology/MTBLS_000279"
                    }
                ],
                "publications": [
                    {
                        "comments": [],
                        "title": "Melatonin enhances function of porcine immature Sertoli cells via modulating gene expression and metabolism",
                        "authorList": "Qiao Mou,Zhi-Qiang Du,Cai-Xia Yang",
                        "pubMedID": "",
                        "doi": "",
                        "status": {
                            "comments": [],
                            "annotationValue": "in preparation",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "132",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0001795"
                        }
                    }
                ],
                "factors": [
                    {
                        "comments": [],
                        "factorName": "Treatment",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "treatment",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "132",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000727"
                        }
                    }
                ],
                "protocols": [
                    {
                        "comments": [],
                        "name": "Sample collection",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Sample collection",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Cells were treated and digested, then collected and centrifuged at 1000 rpm for 5 min. After re-suspension, the number of cells was adjusted to 5 x 106 for both Control (6 replicates) and MT (6 replicates) groups.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Extraction",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Extraction",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>1. Transfer all cell samples into a 2 mL centrifuge tube, add 100 mg glass bead;</p><p>2. Accurately add 1000 \u00b5L acetonitrile (ACN):methanol:H2O mixed solution (2:2:1, v/v/v) (stored at 4 \u00b0C) ,vortex for 30 s;</p><p>3. Put the centrifuge tube containing the sample into the 2 mL adapter matched with the instrument, immerse it in liquid nitrogen for rapid freezing for 5 min, take out the centrifuge tube and thaw at room temperature, put the centrifuge tube into the 2 mL adapter again, install it into the tissue grinder and grind it at 55 Hz for 2 min;</p><p>4. Repeat step 3 twice;</p><p>5. Take out the centrifuge tube, centrifuge for 10 min at 12,000 rpm and 4 \u00b0C, take all the supernatant, transfer it to a new 2 mL centrifuge tube, concentrate and dry it;</p><p>6. Accurately add 300 \u00b5L acetonitrile:2-Amino-3-(2-chloro-phenyl)-propionic acid (4 ppm) solution prepared with 0.1% formic acid (1:9, v/v) (stored at 4 \u00b0C) to redissolve the sample, filter the supernatant by 0.22 \u00b5m membrane and transfer into the detection bottle for LC-MS detection.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Post Extraction",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Derivatization",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Chromatography",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Chromatography",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>The LC analysis was performed on a Vanquish UHPLC System (Thermo Fisher Scientific, USA). Chromatography was carried out with an ACQUITY UPLC HSS T3 (150 x 2.1 mm, 1.8 \u00b5m) (Waters, Milford, MA, USA). The column maintained at 40 \u00b0C. The flow rate and injection volume were set at 0.25 mL/min and 2 \u03bcL, respectively. For LC-ESI (+)-MS analysis, the mobile phases consisted of (C) 0.1% formic acid in acetonitrile (v/v) and (D) 0.1% formic acid in water (v/v). Separation was conducted under the following gradient: 0.0-1.0 min, 2% C; 1.0-9.0 min, 2-50% C; 9.0-12.0 min, 50-98% C; 12.0-13.5 min, 98% C; 13.5-14.0 min, 98-2% C; 14.0-20.0 min, 2% C. For LC-ESI (-)-MS analysis, the analytes was carried out with (A) acetonitrile and (B) ammonium formate (5 mM). Separation was conducted under the following gradient: 0.0-1.0 min, 2% A; 1.0-9.0 min, 2-50% A; 9.0-12.0 min, 50-98% A; 12.0-13.5 min, 98% A; 13.5-14.0 min, 98-2% A; 14.0-17.0 min, 2% A.&nbsp;</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Chromatography Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Autosampler model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column type",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Guard column",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Mass spectrometry",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Mass spectrometry",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Mass spectrometric detection of metabolites was performed on Orbitrap Exploris 120 (Thermo Fisher Scientific, USA) with ESI ion source. Simultaneous MS1 and MS/MS (Full MS-ddMS2 mode, data-dependent MS/MS) acquisition was used. The parameters were as follows: sheath gas pressure, 30 arb; aux gas flow, 10 arb; spray voltage, 3.50 and -2.50 kV for ESI(+) and ESI(-), respectively; capillary temperature, 325 \u00b0C; MS1 range, 100-1000 m/z; MS1 resolving power, 60000 FWHM; number of data dependant scans per cycle, 4; MS/MS resolving power, 15000 FWHM; normalized collision energy, 30%; dynamic exclusion time, automatic.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan polarity",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan m/z range",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Ion source",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Mass analyzer",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Data transformation",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Data transformation",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>The raw data were firstly converted to mzXML format by MSConvert in ProteoWizard software package (v3.0.8789). Peak detection, peak filtering and peak alignment were carried out by using R XCMS software package, and a quantitative list of substances was obtained. The parameters were set as bw = 2, ppm = 15, peakwidth = c(5, 30), mzwid = 0.015, mzdiff = 0.01, and Method = 'CentWave'. The public databases HMDB, massbank, LipidMaps, mzcloud, KEGG and self-built material library were used for material identification, and the parameter was set to ppm &lt; 30 ppm. LOESS signal correction method based on QC samples realizes data correction and eliminates system errors. Materials with RSD &gt; 30% in QC samples are filtered out in data quality control.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Metabolite identification",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Metabolite identification",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>The public databases HMDB, massbank, LipidMaps, mzcloud, KEGG and self-built material library were used for material identification, and the parameter was set to ppm &lt; 30 ppm.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    }
                ],
                "assays": [
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry assay",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Liquid Chromatography MS - positive - reverse phase",
                        "filename": "a_MTBLS11126_LC-MS_positive_reverse-phase_metabolite_profiling-1.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    },
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry assay",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Liquid Chromatography MS - negative - reverse phase",
                        "filename": "a_MTBLS11126_LC-MS_negative_reverse-phase_metabolite_profiling-1.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    }
                ],
                "sources": [],
                "samples": [],
                "processSequence": [],
                "characteristicCategories": [],
                "units": []
            }
        ]
    },
    "validation": {
        "errors": [],
        "warnings": []
    }
}